It’s not uncommon for shareholders to disagree with the boards that are supposed to represent their interests. Directors are privy to a lot of inside information that isn’t available to the public. They make decisions that can’t be divulged, sometimes forever. They balance risks against potential gains in initiatives that don’t always produce the desired
Read More
It’s not a question of AstraZeneca or Pfizer for digital health company ResApp Health (ASX: RAP) who have today entered into a binding scheme implementation deed to be acquired by pharmaceutical giant, Pfizer. Yes, one of the world’s biggest pharma companies has been perusing the ASX for a small homegrown biotech to snap up, we’re
Read More